Optimizing Bioavailability and Antihypertensive Activity of Carvedilol Cubosomes using D-Optimal…
Abstract
Carvedilol (CARV) -a nonselective β-receptor antagonist indicated in treatment of hypertension- suffers from poor oral bioavailability due to its poor solubility and hepatic first-pass metabolism. This study aimed to optimize…